Akzo Nobel N.V.
AKZOF
$57.42
-$1.32-2.25%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.46B | 11.47B | 11.50B | 11.46B | 11.47B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.46B | 11.47B | 11.50B | 11.46B | 11.47B |
| Cost of Revenue | 6.87B | 6.90B | 6.92B | 6.89B | 6.86B |
| Gross Profit | 4.59B | 4.57B | 4.58B | 4.57B | 4.62B |
| SG&A Expenses | 3.36B | 3.34B | 3.36B | 3.35B | 3.35B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -11.33M | -6.83M | 319.02M | 5.35M | 6.54M |
| Total Operating Expenses | 10.54B | 10.55B | 10.92B | 10.56B | 10.53B |
| Operating Income | 919.31M | 917.48M | 579.65M | 896.63M | 942.82M |
| Income Before Tax | 1.13B | 1.14B | 370.03M | 753.81M | 813.29M |
| Income Tax Expenses | 376.74M | 373.32M | 273.24M | 247.99M | 255.10M |
| Earnings from Continuing Operations | 752.43 | 763.86 | 96.79 | 505.82 | 558.18 |
| Earnings from Discontinued Operations | -1.17M | -1.17M | -1.17M | -- | 1.08M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -34.49M | -40.04M | -46.71M | -50.90M | -54.56M |
| Net Income | 716.78M | 722.65M | 48.91M | 454.92M | 504.70M |
| EBIT | 919.31M | 917.48M | 579.65M | 896.63M | 942.82M |
| EBITDA | 1.35B | 1.34B | 993.08M | 1.31B | 1.35B |
| EPS Basic | 4.19 | 4.22 | 0.29 | 2.66 | 2.96 |
| Normalized Basic EPS | 2.35 | 2.34 | 1.22 | 2.47 | 2.66 |
| EPS Diluted | 4.17 | 4.20 | 0.27 | 2.64 | 2.94 |
| Normalized Diluted EPS | 2.34 | 2.33 | 1.21 | 2.45 | 2.65 |
| Average Basic Shares Outstanding | 684.30M | 683.90M | 683.60M | 683.40M | 683.10M |
| Average Diluted Shares Outstanding | 686.06M | 686.42M | 689.58M | 690.16M | 689.96M |
| Dividend Per Share | 2.29 | 2.29 | 2.14 | 2.14 | 2.12 |
| Payout Ratio | 53.49% | 53.45% | 814.99% | 81.89% | 71.54% |